Profile picture
, 3 tweets, 4 min read
My Authors
Read all threads
The promise of convalescent plasma
cbsnews.com/news/coronavir…
seemingly the opposite of super spreader people are "super-donors," about 20% of recovered #COVID19 patients
w/ @MDonatoBMT @HackensackUMC @HMHNewJersey @BillWhitakerCBS
Over 5,000 patients have been treated in the US, some encouraging data for efficacy
"What's left is this gold-colored liquid: plasma"
@60Minutes
Well, recently, it was worth $1,000 (to several thousand) for 1 ml of convalescent plasma
wsj.com/articles/blood… by @deniseroland
Missing some Tweet in this thread? You can try to force a refresh.

Keep Current with Eric Topol

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Related hashtags

#COVID19

More from @EricTopol see all

Profile picture
Eric Topol
@EricTopol
The 1st pandemic research scandal, as @ScienceMagazine aptly puts it, now leads to a retraction of @TheLancet hydroxychloroquine paper by its non-@Surgisphere authors
science.sciencemag.org/content/sci/36…
What still remains unclear is whether the 3 authors, who have now retracted the paper, had access to the primary data that was published. It looks as though they did not. And if so, that violates journal requirements and was a setup for what occurred.
The "only" major difference from the retracted paper v. prior/other 14 studies (10 observational, 4 RCTs) was the ~35% increase in mortality. Otherwise, there was consistency in lack of efficacy (and risk of heart arrhythmias in many).
Now there's no data to support ⬆️ mortality
Read 7 tweets
Profile picture
Eric Topol
@EricTopol
Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions
Lots of buzz yesterday about the @NEJM hydroxychloroquine trial without noting it was done remotely
nejm.org/doi/10.1056/NE…
And a feature @NatureNews
nature.com/articles/d4158…
This succinct essay @TheLancet provides perspective on this model of clinical trials, by @SteveSteinhubl @ScrippsRTI @scrippsresearch
thelancet.com/journals/lance…
The 1st published siteless clinical trial at scale
jamanetwork.com/journals/jama/… @JAMA_current @ScrippsRTI
Read 3 tweets
Profile picture
Eric Topol
@EricTopol
We just published a review of 16 cohorts w/ #COVID19 + data for asymptomatic infections
@AnnalsofIM
great work by @danieloran @ScrippsRTI @scrippsresearch
acpjournals.org/doi/10.7326/M2…
Bottom line: the rate is high, perhaps ~40% or greater, even taking into account presymptomatic Δ
Besides the high rate of people infected but lacking symptoms, it is noteworthy what is going on beneath the surface. For example:
1 cohort of 331 (46.5%) were asymptomatic. But CT scans in 76 of these individuals, 54% showed significant abnormalities c/w #COVID19.
There's also a lot of data about children from the 16 cohorts.
One of the most careful studies was in Vo, Italy:
“No infections were detected in either survey in 234 tested children ranging from 0 to 10 years, despite some of them living in the same household as infected people”
Read 4 tweets

Embed code for your website

×
Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!